Rapiblyk (Landiolol)

Rapiblyk (landiolol) is a beta-adrenergic blocker used for the short-term reduction of ventricular rate in adult patients with supraventricular tachycardia including atrial fibrillation and atrial flutter.

Recommended Dosage: The recommended dose of Landiolol should be administered as a continuous intravenous infusion. Dosage can be titrated as required for heart rate control, with limited data beyond 24 hours. For normal cardiac function, start at 9 mcg/kg/min, increase by 9 mcg/kg/min every 10 minutes, up to a maximum of 36 mcg/kg/min. For impaired cardiac function, start at 1 mcg/kg/min, increase by 1 mcg/kg/min every 15 minutes, up to the same maximum dose. Note that 9 mcg/kg/min of landiolol equals 9.6 mcg/kg/min of landiolol hydrochloride.

• A drop in blood pressure may occur with the usage of Landiolol 280 mg injection. Patients should be under close observation for the development of hypotension and dizziness during the infusion. The infusion should be reduced or stopped if severe hypotension occurs during the procedure.
• Decreased heart rate can occur in patients while using Landiolol. Patients should be under constant supervision and the heart rate maintained within safe limits. If there’s development of severe bradycardia or symptoms such as fatigue and discomfort in the chest area, reduce or stop the infusion.
• While using this drug some patients may have a Congestive Heart Failure episode. Patients must be supervised for breathlessness and muscle pulsation. They should be encouraged to use caution while performing activity and If their heart muscle strength noticeably decreases, the medication should be withdrawn.
• If a patient has a medical history of asthma or a chronic obstructive pulmonary disease then they would be advised against using this medicine as it leads to breathing difficulty and chest tightness along with major wheezing. The dose should be tapered to prevent infusion of past medications.
• Some patients using Landiolol may show some signs of inflammation and tenderness on their skin such as redness or swelling while changing their media, which should be monitored during their supplemental dosage therapy. In cases where the signs are more severe, then they can merge the inhibition with an anti-inflammation therapy.
• There is limited data on the use of Rapiblyk 280 mg injection during pregnancy. Administer only if the benefits outweigh the risks to the fetus. Pregnant women should consult a healthcare provider before starting the treatment.
• It is unclear if Landiolol passes into breast milk. Breastfeeding mothers should use this medicine cautiously. Discuss potential risks and benefits with a healthcare provider before using this drug during breastfeeding.

What documents are required to import RAPIBLYK to India?

RAPIBLYK (landiolol) for injection can be imported by patients or government hospitals on the name of the patients only.
The following documentation is required to import the product:

• A valid prescription from a qualified doctor.
• Patients diagnostic reports
• Patient ID proof (issued by the government of India)

How does the order be confirmed?

The order will be confirmed only after the receipt of:

• A valid prescription from the Doctor
• Import permit if applicable

Is RAPIBLYK available in India?

RAPIBLYK (landiolol injection) is a (prescription drug, prescription medication, or prescription medicine) pharmaceutical drug that legally requires a medical prescription to be dispensed.

IPN (Indian Pharma Network) helps import cancer medicines on the named patient supply (NPS). Indian Pharma Network is the facilitator providing input

• On availability of Rapiblyk in India (Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Pune etc.)
• On availability in Gulf countries (Bahrain, Oman, Qatar, Kuwait, Iraq, Saudi Arabia, and the UAE).
• Medicine Price.
  Finding Genuine and reliable sources from the USA, Canada, Europe, and Australia
• Ensuring 100% transparency.

RAPIBLYK can be made available to patients, doctors, and hospitals in Mumbai, Goa, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, Lucknow, and Pune and other cities in India. The order will be confirmed only after the receipt of a valid prescription from the doctor and an import permit.

IPN (Indian Pharma Network) can facilitate the supply of RAPIBLYK (prescription medicines) to all locations in the world and India after fulfilling the legal requirement (if applicable).

Please contact +91-9310090915 | Toll-Free Number: 1800-889-1064 or write us at info@indianpharmanetwork.in for Rapiblyk 280 mg injection price in India.

We guarantee quality and delivery anywhere in the world as per the buyer’s requirements.

Indian Pharma Network can source RAPIBLYK (Cancer Treatment Medicines) from across the globe and can supply. Indian Pharma offers its customers worldwide access to the best available treatment.

Indian Pharma Network (IPN) can dispense any valid prescription in the shortest possible time. All prescriptions are dispensed and checked by registered pharmacists and dispatched to the Patient's address only from New Delhi, India.

What is the Generic Name for the trade name drug Rapiblyk®?

Landiolol is a Generic Name for the trade name drug Rapiblyk®.

What is the Manufacturer's Name of Rapiblyk®?

Rapiblyk® is manufactured by AOP Orphan Pharmaceuticals.

Is Rapiblyk® approved by the FDA?

Yes, Rapiblyk® is approved by the FDA. Date of first approval: November 22, 2024.

What is the dosage and form of Rapiblyk® supplied?

Rapiblyk is supplied for injection: 280 mg of landiolol (equivalent to 300 mg of landiolol HCl) as a lyophilized powder in a single-dose vial for intravenous use.

What are the most common side effects of Rapiblyk® injection?

The most common side effect of Rapiblyk® is hypotension.

How much does Rapiblyk® 280 mg injection cost in India?

Prices of Rapiblyk 280 mg may fluctuate over time because of market dynamics and regulatory changes. To get the most recent details on Rapiblyk injection cost in India, please Call/WhatsApp +91-9310090915 or send mail to info@indianpharmanetwork.in.

Can Rapiblyk® 280 mg injection be available in SAARC countries?

Apart from Gulf countries, Rapiblyk® can be available in SAARC countries (India, Afghanistan, Maldives, Nepal, Bangladesh, Bhutan, Pakistan, and Sri Lanka). Indian Pharma Network (IPN) can help facilitate the legal supply of Rapiblyk® injections in these countries. We help ensure legal access to this therapeutic drug through our reliable channels.

Is it safe to buy Rapiblyk® injections online in India?

Yes, one can buy Rapiblyk online in India at the lowest price from the Indian Pharma Network (IPN) if this medicinal product is not (yet) registered or available in their country. We can facilitate the legal supply of Rapiblyk® injections through legal channels.

What are the storage conditions of Rapiblyk® injections?

Store unreconstituted product at 20°C to 25°C (68°F to 77°F), with excursions permitted to 15°C to 30°C (59°F to 86°F).